ADMA BIOLOGICS, INC. 10-K filing
Filed 2026-02-25 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001140361-26-006815
- Form type
- 10-K
- CIK
- 0001368514
- Primary document
- https://www.sec.gov/Archives/edgar/data/1368514/000114036126006815/ef20059416_10-k.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ADMA BIOLOGICS, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $510.2M | - | - |
| Cost Of Revenue | $217.4M | - | - |
| Gross Profit | $292.8M | - | - |
| Operating Income | $191.4M | - | - |
| Net Income | $146.9M | - | - |
| Eps Basic | 0.62 | - | - |
| Eps Diluted | 0.6 | - | - |
| Cash And Equivalents | $87.6M | - | - |
| Total Assets | $624.2M | - | - |
| Total Liabilities | $146.9M | - | - |
| Shareholders Equity | $477.3M | - | - |
| Operating Cash Flow | $50.4M | - | - |
| Capital Expenditures | $22.6M | - | - |